These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34214882)

  • 1. Buprenorphine abuse and health risks in Iran: A systematic review.
    Ansari M; Rostam-Abadi Y; Baheshmat S; Hamzehzadeh M; Gholami J; Mojtabai R; Rahimi-Movaghar A
    Drug Alcohol Depend; 2021 Sep; 226():108871. PubMed ID: 34214882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tramadol use and public health consequences in Iran: a systematic review and meta-analysis.
    Rostam-Abadi Y; Gholami J; Amin-Esmaeili M; Safarcherati A; Mojtabai R; Ghadirzadeh MR; Rahimi H; Rahimi-Movaghar A
    Addiction; 2020 Dec; 115(12):2213-2242. PubMed ID: 32196801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public health risks associated with methadone in Iran: A systematic review and meta-analysis.
    Rostam-Abadi Y; Gholami J; Noroozi A; Ansari M; Baheshmat S; Hamzehzadeh M; Ghadirzadeh MR; Vahdani B; Ekhtiari H; Mojtabai R; Rahimi-Movaghar A
    Int J Drug Policy; 2022 Feb; 100():103529. PubMed ID: 34826790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription opioid abuse in prison settings: A systematic review of prevalence, practice and treatment responses.
    Bi-Mohammed Z; Wright NM; Hearty P; King N; Gavin H
    Drug Alcohol Depend; 2017 Feb; 171():122-131. PubMed ID: 28086177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.
    Connock M; Juarez-Garcia A; Jowett S; Frew E; Liu Z; Taylor RJ; Fry-Smith A; Day E; Lintzeris N; Roberts T; Burls A; Taylor RS
    Health Technol Assess; 2007 Mar; 11(9):1-171, iii-iv. PubMed ID: 17313907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discontinuation of buprenorphine maintenance therapy: perspectives and outcomes.
    Bentzley BS; Barth KS; Back SE; Book SW
    J Subst Abuse Treat; 2015 May; 52():48-57. PubMed ID: 25601365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of sex differences in treatment outcomes among people with opioid use disorder receiving buprenorphine maintenance versus other treatment conditions.
    Ling S; Mangaoil R; Cleverley K; Sproule B; Puts M
    Drug Alcohol Depend; 2019 Apr; 197():168-182. PubMed ID: 30831429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On my own terms: Motivations for self-treating opioid-use disorder with non-prescribed buprenorphine.
    Silverstein SM; Daniulaityte R; Miller SC; Martins SS; Carlson RG
    Drug Alcohol Depend; 2020 May; 210():107958. PubMed ID: 32203863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication-assisted treatment with buprenorphine: assessing the evidence.
    Thomas CP; Fullerton CA; Kim M; Montejano L; Lyman DR; Dougherty RH; Daniels AS; Ghose SS; Delphin-Rittmon ME
    Psychiatr Serv; 2014 Feb; 65(2):158-70. PubMed ID: 24247147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of buprenorphine maintenance treatment as compared to a syringe exchange program among buprenorphine misusing opioid-dependent patients.
    Aalto M; Visapää JP; Halme JT; Fabritius C; Salaspuro M
    Nord J Psychiatry; 2011 Sep; 65(4):238-43. PubMed ID: 21047194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Opioid Substances Acute Poisonings with Suicidal Intent in Patients with Opioid Use Disorder.
    Simonovska NK; Stefanovska VV; Babulovska A
    Folia Med (Plovdiv); 2020 Mar; 62(1):117-123. PubMed ID: 32337915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine in the United States: Motives for abuse, misuse, and diversion.
    Chilcoat HD; Amick HR; Sherwood MR; Dunn KE
    J Subst Abuse Treat; 2019 Sep; 104():148-157. PubMed ID: 31370979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric Comorbidity and Substance Use Outcomes in an Office-Based Buprenorphine Program Six Months Following Hurricane Sandy.
    Tofighi B; Grossman E; Goldfeld KS; Williams AR; Rotrosen J; Lee JD
    Subst Use Misuse; 2015; 50(12):1571-8. PubMed ID: 26623697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of buprenorphine and methadone among opioid users who inject drugs.
    Tsui JI; Burt R; Thiede H; Glick SN
    Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.
    Fox AD; Maradiaga J; Weiss L; Sanchez J; Starrels JL; Cunningham CO
    Addict Sci Clin Pract; 2015 Jan; 10(1):2. PubMed ID: 25592182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic.
    Currie JM; Schnell MK; Schwandt H; Zhang J
    JAMA Netw Open; 2021 Apr; 4(4):e216147. PubMed ID: 33856474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in mortality risk with opioid agonist therapy: a systematic review and meta-analysis.
    Bahji A; Cheng B; Gray S; Stuart H
    Acta Psychiatr Scand; 2019 Oct; 140(4):313-339. PubMed ID: 31419306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.
    DeFlavio JR; Rolin SA; Nordstrom BR; Kazal LA
    Rural Remote Health; 2015; 15():3019. PubMed ID: 25651434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis?
    Doernberg M; Krawczyk N; Agus D; Fingerhood M
    Subst Abus; 2019; 40(2):148-153. PubMed ID: 31008694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and treatment of opioid use disorders among primary care patients in six health systems.
    Lapham G; Boudreau DM; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Samet JH; Saxon AJ; Campbell CI; Glass JE; Rossom RC; Murphy MT; Binswanger IA; Yarborough BJH; Bradley KA;
    Drug Alcohol Depend; 2020 Feb; 207():107732. PubMed ID: 31835068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.